31 studies were found.

1.		Recruiting	Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections
2.		Recruiting	Anti-Human CD45 Monoclonal Antibodies in Patients with Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation Condition: Leukemia
3.		Recruiting	Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients Condition: Neuroblastoma
4.		Terminated	Bone marrow transplant from donor using less toxic conditioning for patient with high risk hemoglobinopathies Conditions: Sickle Cell Anemia; Hemoglobinopathy; Thalassemia
5.		Terminated	Bone Marrow transplant from related donor for patients with high risk hemoglobinopathies Conditions: Sickle Cell Anemia; Hemoglobinopathy; Thalassemia
6.		Recruiting	Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients with Hematological Diseases Condition: Hematologic Malignancy
7.		Recruiting	Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant Conditions: Stem Cell Transplantation; Cytomegalovirus Infections
8.		Recruiting	EBV-Specific CTLs Following CD45 Antibody to Patients with Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) Conditions: Nasopharyngeal Cancer; EBV Infections
9.		Recruiting	The Effect of Oral Magnesium Pidolate on How Often Painful Crises Happens in Patients with Hemoglobin SC Disease Condition: Hemoglobin SC Disease
10.		Recruiting	Gene Marked Cytotoxic T-cells for Patients with Relapsed Hodgkin's Lymphoma Condition: Hodgkin Disease
11.		Recruiting	Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients who have had Donor Marrow Grafts. Conditions: Bone Marrow Transplantation; Epstein-Barr Virus Infections
12.		Recruiting	Giving Gene Marked (Optional) Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Patients with Relapsed EBV-Positive Lymphoma, Conditions: Hodgkins Disease; Non-Hodgkins Lymphoma
13.		Recruiting	Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease Conditions: Hodgkin Disease; Non-Hodgkins Lymphoma
14.		Recruiting	Intrathecal Gemcitabine to Treat Neoplastic Meningitis Conditions: Meningitis; Neoplasms
15.		Recruiting	Intrathecal Mafosfamide Condition: Malignant Meningeal Neoplasms
16.		Recruiting	LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma Condition: Lymphoma
17.		Terminated	Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients with Inherited Metabolic Storage Diseases Condition: Inherited Metabolic Storage Diseases
18.		Recruiting	A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients with Fanconi Anemia. Condition: Fanconi's Anemia
19.		No longer recruiting	Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy Condition: Neuroblastoma
20.		Recruiting	A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients Condition: Neoplasms
21.		Recruiting	Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). Conditions: Epstein-Barr Virus Infections; Lymphoproliferative Disorders
22.		Completed	Stem Cell Transplant for Patients with Blood Malignancy Using Donors and Less Toxic Chemotherapy with CAMPATH 1H Conditions: Myelodysplastic Disorders; Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders
23.		Recruiting	Stem Cell Transplant for Patients with Hematologic Diseases and Renal Cell Cancer Using Family Donors and Conditioning with Campath-1H Condition: Hematologic Malignancies
24.		Terminated	Stem Cell Transplantation for Patients with Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning with CAMPATH 1H Condition: Graft Failure
25.		Recruiting	Study of Irinotecan in Children. Condition: Cancer
26.		Recruiting	Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors Condition: Brain Tumors
27.		No longer recruiting	Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine. Condition: Leukemia
28.		Recruiting	Treating Severe Chronic Epstein-Barr Virus (EBV) Infection with EBV Specific Cytotoxic T Lymphocytes (CTLs) Condition: Epstein-Barr Virus Infections
29.		No longer recruiting	Treatment of Resistant Langerhans Cell Histiocytosis with ENBREL Condition: Histiocytosis, Langerhans-Cell
30.		No longer recruiting	Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma. Condition: Neuroblastoma
31.		Recruiting	Valacyclovir in Immunocompromised Children Conditions: Shingles; Bone Marrow Transplantation